| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |